Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Establishment of a Brain and Spinal Tumor Tissue Bank
- Status
- UNKNOWN
- Phase
- N/A
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
- Status
- WITHDRAWN
- Phase
- N/A
Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE1
Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
- Status
- TERMINATED
- Phase
- N/A
Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
- Status
- TERMINATED
- Phase
- PHASE2
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2